What's Happening?
Minnesota Lynx forward Napheesa Collier will miss the beginning of the 2026 WNBA season following surgery on her left ankle. The surgery, which took place on March 24, was part of a recovery plan after
Collier sustained multiple injuries during the 2025 season. The Lynx announced that her rehabilitation is progressing as expected, with a projected return to the court in early June. Collier's absence will see her miss the team's preseason games and the first eight matches of the season, including the opener against the Atlanta Dream. Despite her injuries, Collier recently signed a one-year, $1.4 million supermax contract with the Lynx, keeping her with the team until she becomes an unrestricted free agent in 2027.
Why It's Important?
Collier's absence is significant for the Minnesota Lynx as they aim to reclaim their championship status, having last won the title in 2017. As a key player, her performance is crucial to the team's success. The timing of her surgery and recovery means the Lynx will need to adjust their strategies and rely on other players to fill the gap during her absence. This situation also highlights the physical demands and injury risks associated with professional sports, particularly in the WNBA, where player health and team dynamics are closely intertwined. Collier's decision to sign a short-term contract reflects her focus on immediate recovery and team success, rather than long-term commitments.
What's Next?
The Lynx will need to navigate the early part of the season without one of their star players, which could impact their standings and playoff prospects. The team will likely provide further updates on Collier's recovery as the season progresses. Her return in June will be closely watched, as it could significantly boost the team's performance. Additionally, Collier's future contract negotiations will be influenced by her recovery and performance post-injury, potentially affecting her market value and career trajectory.
